What is Joint Preservation?
The words maintenance and preservation are thrown around an awful lot. Especially when it comes to joint health in the…
Posts by tag: Pharmaceuticals
Hepatitis C Drug Receives Priority Review
According to an article released by NASDAQ today, the United States Food and Drug Administration (FDA) has taken their “breakthrough…
Mother’s Blog Gives Years of Personal Experience with Family and Hemophilia
WeBleed is pleased to share a mother’s blog titled “2 Brothers with Hemophilia: The Journey of 2 Brothers with Severe…
Pharma/Biotech Update: Biogen Idec’s Long Acting Drug Receives FDA Approval
The wait is over. Biogen Idec has officially received word from the U.S. Food and Drug Administration about the approval of…
Pharma/Biotech Update: Baxter To Add Public Company in 2015
Baxter International Inc. has announced plans to spin-off it’s biotech division and make that area of business its own company….
CSL Behring Grant Gives Medical Professionals Guidance with Affordable Care Act
Understanding the Affordable Healthcare Act (ACA) can be a challenge. With the introduction of the ACA a few years ago…
KASHMIR – HEMOPHILIA PATIENTS INFECTED BY HEPATITIS C
Kashmir, a country located in the southwestern region of India released an all too familiar story yesterday via Greater Kashmir….
KOREA – BAYER KOREA STOPS SELLING KOGENATE FS IN COUNTRY
News out of Korea today via The Korea Times is breaking a story stating that Bayer has decided to stop importing…
FLORIDA – HEMOPHILIA FEDERATION OF AMERICA ANNUAL SYMPOSIUM
Who: Hemophilia Federation of America (HFA) What: HFA Annual Symposium Where: Tampa, Florida When: March 27 – 29, 2014 Click…
PHARMA/BIO-TECH UPDATE: BIOGEN IDEC’S NEW HEMOPHILIA DRUG APPROVED IN CANADA
Canada’s approval of Biogen Idec’s long-acting hemophilia B drug may be a foreshadowing into other major countries approving ALPROLIX as…